Skip to main content

Publisher: Elsevier

Volume 61, Number 1, 1 May 2003

Editorial Board
pp. ii-ii(1)

Favourites:
ADD

Increased phospholipase A2 activity in schizophrenia with absent response to niacin
pp. 1-6(6)
Authors: Tavares, H.; Yacubian, J.; Talib, L.L.; Barbosa, N.R.; Gattaz, W.F.

Favourites:
ADD

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis - I. Study rationale and design
pp. 7-18(12)
Authors: McGlashan, T.H.; Zipursky, R.B.; Perkins, D.; Addington, J.; Miller, T.J.; Woods, S.W.; Hawkins, K.A.; Hoffman, R.; Lindborg, S.; Tohen, M.; Breier, A.

Favourites:
ADD

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis - II. Baseline characteristics of the ''prodromal'' sample
pp. 19-30(12)
Authors: Miller, T.J.; Zipursky, R.B.; Perkins, D.; Addington, J.; Woods, S.W.; Hawkins, K.A.; Hoffman, R.; Preda, A.; Epstein, I.; Addington, D.; Lindborg, S.; Marquez, E.; Tohen, M.; Breier, A.; McGlashan, T.H.

Favourites:
ADD

Association between a promoter variant in the monoamine oxidase A gene and schizophrenia
pp. 31-37(7)
Authors: Jonsson, E.G.; Norton, N.; Forslund, K.; Mattila-Evenden, M.; Rylander, G.; ├ůsberg, M.; Owen, M.J.; Sedvall, G.C.

Favourites:
ADD

TNFB polymorphism may be associated with schizophrenia in the Korean population
pp. 39-45(7)
Authors: Jun, T.; Pae C.-U.; Chae, J.; Bahk, W.; Kim, K.; Han, H.; Serretti, A.

Favourites:
ADD

The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis
pp. 47-57(11)
Authors: Emsley, R.; Rabinowitz, J.; Torreman, M.; The RIS-INT-35 Early Psychosis Global Working Group

Favourites:
ADD

Anhedonia in schizophrenia: a distinct familial subtype?
pp. 59-66(8)
Authors: Schurhoff, F.; Szoke, A.; Bellivier, F.; Turcas, C.; Villemur, M.; Tignol, J.; Rouillon, F.; Leboyer, M.

Favourites:
ADD

Minor physical anomalies in schizophrenia: is age a confounding factor?
pp. 67-73(7)
Authors: Lloyd, T.; Doody, G.; Brewin, J.; Park, B.; Jones, P.

Favourites:
ADD

Insight in schizophrenia: a meta-analysis
pp. 75-88(14)
Authors: Mintz, A.R.; Dobson, K.S.; Romney, D.M.

Favourites:
ADD

Anxiety and substance use comorbidity among inpatients with schizophrenia
pp. 89-95(7)
Authors: Goodwin, R.D.; Amador, X.F.; Malaspina, D.; Yale, S.A.; Goetz, R.R.; Gorman, J.M.

Favourites:
ADD

A confirmatory factor analytic evaluation of the pentagonal PANSS model
pp. 97-104(8)
Authors: Fitzgerald, P.B.; de Castella, A.R.; Brewer, K.; Filia, K.; Collins, J.; Davey, P.; Rolfe, T.; Kulkarni, J.

Favourites:
ADD

Increasing age does not decrease risk of schizophrenia up to age 40
pp. 105-110(6)
Authors: Haukka, J.; Suvisaari, J.; Lonnqvist, J.

Favourites:
ADD

Dopamine D4 receptor gene (DRD4) variants and schizophrenia: meta-analyses
pp. 111-119(9)
Authors: Jonsson, E.G.; Sedvall, G.C.; Nothen, M.M.; Cichon, S.

Favourites:
ADD

EEG brain mapping in schizophrenic patients and healthy subjects during facial emotion recognition
pp. 121-122(2)
Authors: Streit, M.; Brinkmeyer, J.; Wolwer, W.; Gaebel, W.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more